The FDA has issued a recall for over 7,100 bottles of the popular antidepressant duloxetine, sold under the brand name Cymbalta. This urgent recall follows the detection of a potentially cancer-causing chemical found in the medication. The FDA has upgraded the risk classification of this recall to the second highest level, prompting concerns for patients currently taking these antidepressants. Consumers are advised to check their prescriptions and consult healthcare professionals regarding the potential risks associated with this recall.